A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/-Reference-Cited by-同舟云学术

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/

Published:2000-03 Issue:4 Volume:108 Page:282-289
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Winston Drew J,Hathorn James W,Schuster Mindy G,Schiller Gary J,Territo Mary C

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Opportunistic mycoses in the immunocompromised host;Anaissie;Clin Infect Dis,1992

2. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients;Walsh;Infect Dis Clin North Am,1996

3. Fungal infections and the cancer patient;Ribaud;Eur J Cancer,1997

4. Problems in the diagnosis of invasive fungal diseases;Rinaldi;Rev Infect Dis,1991

5. Fungal infections in cancer patients;Bodey;Eur J Clin Microbiol Infect Dis,1992

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review;Antibiotics;2023-08-19

2. Effectiveness of fluconazole as antifungal prophylaxis in cancer patients undergoing chemotherapy, radiotherapy, or immunotherapy: systematic review and meta‐analysis;APMIS;2023-05-18

3. Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series;Internal Medicine;2022-10-15

4. Phytopharmaceuticals for the Management of Fungal Infections;Herbal Drugs for the Management of Infectious Diseases;2022-08

5. Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021;Internal Medicine Journal;2021-11